Nausheen Ahmed, MD
Advertisement
Nausheen Ahmed, MD, is an associate professor of hematologic malignancies and cellular therapeutics at the University of Kansas Medical Center.
Articles by Nausheen Ahmed, MD
Nausheen Ahmed, MD, discusses the guidelines for monitoring patients after receiving CAR T-cell therapy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Ziftomenib in NPM1-Mutant Acute Myeloid Leukemia
2
FDA Approves Novel Interchangeable Biosimilar for Pertuzumab in HER2+ Breast Cancer
3
MB-105 Gains FDA RMAT Designation in R/R T-Cell Lymphoma
4
Five-Year CAR T Data Reflect Long-Term PFS in Multiple Myeloma
5
